Adverse outcomes in patients with chronic liver disease undergoing colorectal surgery

Annals of Surgery

Volumn 252, Issue 2, 2010, Pages 345-350

  Ghaferi, Amir A ^a   Mathur, Amit K ^a   Sonnenday, Christopher J ^a   Dimick, Justin B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; STEROID;

ADULT; ADVERSE OUTCOME; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; CHRONIC LIVER DISEASE; COLON RESECTION; COLORECTAL SURGERY; CONTROLLED STUDY; DISEASE SEVERITY; ESOPHAGUS VARICES; FEMALE; HEALTH CARE QUALITY; HUMAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM RESECTION; RISK ASSESSMENT; SCORING SYSTEM;

AGED; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; COLORECTAL SURGERY; FEMALE; HUMANS; LIVER DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS;

EID: 77955172758     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181e982d6     Document Type: Article

References (24)

1. Yoon YH, Yi H. Surveillance Report 83, Liver Cirrhosis Mortality in the United States, 1970-2005. Arlington, VA: National Institute on Alcohol Abuse and Alcoholism, Division of Epidemiology and Prevention Research, Alcohol Epidemiologic Data System; 2008.
2. Metcalf AM, Dozois RR, Wolff BG, et al. The surgical risk of colectomy in patients with cirrhosis. Dis Colon Rectum. 1987;30:529-531.
3. Meunier K, Mucci S, Quentin V, et al. Colorectal surgery in cirrhotic patients: assessment of operative morbidity and mortality. Dis Colon Rectum. 2008; 51:1225-1231.
4. ACS NSQIP. Data collection overview. Available at: https://acsnsqip.org/ main/program-data-collection.asp. Accessed February 26, 2009.
5. American Medical Association. CPT 2006: Current Procedural Terminology. Chicago, IL: American Medical Association; 2005.
6. Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 2005;42(suppl 1):S100-S107.
7. Freeman RB Jr, Wiesner RH, Roberts JP, et al. Improving liver allocation: MELD and PELD. Am J Transplant. 2004;4(suppl 9):114-131.
8. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepa-tology. 2000;31:864-871.
9. Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl. 2001;7:567-580.
10. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124:91-96.
11. Martin AP, Bartels M, Hauss J, et al. Overview of the MELD score and the UNOS adult liver allocation system. Transplant Proc. 2007;39:3169-3174.
12. Ailawadi G, Lapar DJ, Swenson BR, et al. Model for end-stage liver disease predicts mortality for tricuspid valve surgery. Ann Thorac Surg. 2009;87: 1460-1467; discussion 1467-1468.
13. Farnsworth N, Fagan SP, Berger DH, et al. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg. 2004;188:580-583.
14. Hoteit MA, Ghazale AH, Bain AJ, et al. Model for end-stage liver disease score versus child score in predicting the outcome of surgical procedures in patients with cirrhosis. World J Gastroenterol. 2008;14:1774-1780.
15. Northup PG, Wanamaker RC, Lee VD, et al. Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg. 2005;242:244-251.
16. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280:1690-1691.
17. Heidelbaugh JJ, Bruderly M. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation. Am Fam Physician. 2006;74:756-762.
18. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217-231.
19. Amitrano L, Guardascione MA, Bennato R, et al. MELD score and hepato-cellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices. J Hepatol. 2005;42:820-825.
20. Alessandria C, Ozdogan O, Guevara M, et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology. 2005;41:1282-1289.
21. Schepke M, Appenrodt B, Heller J, et al. Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study. Liver Int. 2006;26:834-839.
22. Kremers WK, van IM, Kim WR, et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology. 2004;39:764-769.
23. Bonney GK, Aldersley MA, Asthana S, et al. Donor risk index and MELD interactions in predicting long-term graft survival: a single-centre experience. Transplantation. 2009;87:1858-1863.
24. Samada Suarez M, Hernandez Perera JC, Ramos Robaina L, et al. Factors that predict survival in patients with cirrhosis considered for liver transplantation. Transplant Proc. 2008;40:2965-2967.